Thyroid cancer is a complex beast, and doctors are always looking for better ways to fight it. As new, super-specific treatments become available, it is crucial to identify the right patients who will benefit from them. This is where biomarker testing comes in. It is a fancy term for checking the unique features of a tumor to predict how it will behave and respond to...
Shari Redstone, the 71-year-old head of Paramount Global, is fighting a tough battle. She recently revealed that she was diagnosed with thyroid cancer. This news came out as she is trying to finalize a major deal with Skydance Media. The deal is important because it will merge Skydance with Paramount, which owns CBS and other media outlets. This merger is still wa...
Thyroid cancer is not always a death sentence. Many people beat it. But some folks have a rougher time. This is especially true for those with aggressive types of papillary thyroid cancer (PTC). These types can be real troublemakers. They don't play by the rules and can be tough to treat. Sadly, not much research has been done on why some patients fare worse th...
Thyroid cancer is often seen as a manageable condition. But for those who face distant metastasis, the journey is far from easy. Distant metastasis means cancer has spread to other parts of the body. This can lead to serious physical and emotional hurdles. To shed light on these challenges, a study focused on the experiences of thyroid cancer survivors dealing with d...
Thyroid cancer has been a topic of concern in Kazakhstan, especially in the East Kazakhstan Region. This area is close to the former Semipalatinsk nuclear test site. The last ten years, from 2013 to 2023, have seen shifts in how often people get thyroid cancer and how many die from it. The Semipalatinsk nuclear test site was once a major location for nuclear testing...
Thyroid cancer is the most common cancer of the endocrine system and head-and-neck region. However, there is a lack of data on how this cancer affects adolescents and young adults (AYAs). A recent study sought to change that by estimating the global burden of thyroid cancer among AYAs from 1990 to 2021. This study is a part of the Global Burden of Disease Study 2021...
Imagine finding out that cancer can change its genes when it travels. This change could be a big deal for figuring out how to beat thyroid cancer. Usually, doctors look at cancer samples to find out what kind of cancer we're dealing with. They want to know the cancer's genetic makeup. DNA test will help them know the best treatment. This is part of a thing called...
Thyroid cancer, particularly Anaplastic Thyroid Cancer (ATC), is known for its aggressiveness and poor prognosis. One key factor influencing this is the tumor immune microenvironment (TIME). To better understand this, scientists used single-cell RNA sequencing (scRNA-seq) to analyze the immune microenvironment of ATC and Papillary Thyroid Cancer (PTC). They found tha...
Meet collagenases – tiny enzymes with a big job in cancer. They're part of a group called matrix metalloproteinases (MMPs), and they help cancer cells spread and invade. But spotting these enzymes in action isn't easy with traditional methods like substrate zymography and in situ zymography. They're not great at showing local activities right in the cells. Enter "cel...
In Korea, doctors are exploring a new way to manage low-risk thyroid cancer. Instead of rushing into surgery, they're considering an approach called active surveillance (AS). This means keeping a close eye on the cancer without immediate surgery. But not all doctors are ready to embrace this idea. A recent survey found several concerns. Let's dive into what's holding...